TEVA NEUROSCIENCE ANNOUNCES AZILECT IS NOW AVAILABLE IN PHARMACIES
Teva Neuroscience announced today the launch of AZILECT (rasagiline tablets),
the first, once-daily treatment for Parkinson's disease (PD) now available in
pharmacies by prescription only. This is important news for the majority (83%)
of respondents in a survey of those living with PD who report taking their PD
medications up to five times/day.